POSACONAZOLE

POSACONAZOLE was reported 16564 times

POSACONAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NPM1 GENE MUTATION 11 0.7857
1 PSEUDOALDOSTERONISM 97 0.4899
2 PROTOTHECOSIS 34 0.3617
3 ANTIBIOTIC LEVEL BELOW THERAPEUTIC 29 0.2843
4 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 17 0.2742
5 LEFT ATRIAL HYPERTROPHY 11 0.2200
6 DEMODICIDOSIS 19 0.2065
7 FUSARIUM INFECTION 118 0.1686
8 MICROSPORIDIA INFECTION 50 0.1425
9 ADENOVIRUS REACTIVATION 20 0.1389
10 APPARENT MINERALOCORTICOID EXCESS 8 0.1379
11 GEOTRICHUM INFECTION 29 0.1374
12 CHIMERISM 11 0.1236
13 ACANTHAMOEBA INFECTION 23 0.1223
14 CEREBRAL VENTRICLE COLLAPSE 9 0.1200
15 CORYNEBACTERIUM BACTERAEMIA 10 0.1176
16 SCEDOSPORIUM INFECTION 83 0.1176
17 ENCEPHALITIS FUNGAL 10 0.1111
18 DISSEMINATED TOXOPLASMOSIS 13 0.1083
19 ALLOGENIC STEM CELL TRANSPLANTATION 17 0.1076
20 BRONCHIOLITIS OBLITERANS SYNDROME 18 0.1029
21 BK POLYOMAVIRUS TEST POSITIVE 9 0.0938
22 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 16 0.0925
23 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 21 0.0905
24 DIFFERENTIATION SYNDROME 65 0.0886
25 HEPATOSPLENIC CANDIDIASIS 13 0.0884
26 OVERGROWTH FUNGAL 9 0.0874
27 PULMONARY MUCORMYCOSIS 43 0.0814
28 ENTEROBACTER BACTERAEMIA 24 0.0792
29 DISSEMINATED COCCIDIOIDOMYCOSIS 11 0.0780
30 ACUTE MYELOID LEUKAEMIA RECURRENT 164 0.0763
31 ACUTE MYELOID LEUKAEMIA REFRACTORY 13 0.0756
32 PRIMARY ADRENAL INSUFFICIENCY 23 0.0754
33 EYE INFECTION FUNGAL 28 0.0724
34 ADENOVIRAL HEPATITIS 17 0.0723
35 MUCORMYCOSIS 187 0.0719
36 GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0692
37 RHINOCEREBRAL MUCORMYCOSIS 23 0.0663
38 LIP SQUAMOUS CELL CARCINOMA 11 0.0655
39 MYCETOMA MYCOTIC 9 0.0647
40 PHAEOHYPHOMYCOSIS 31 0.0647
41 SYSTEMIC MYCOSIS 75 0.0642
42 LABELLED DRUG-DRUG INTERACTION ISSUE 92 0.0635
43 MYCOTIC ENDOPHTHALMITIS 12 0.0635
44 CEREBRAL ASPERGILLOSIS 39 0.0634
45 CUTANEOUS MUCORMYCOSIS 11 0.0598
46 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 12 0.0591
47 ELECTROCARDIOGRAM PR SHORTENED 12 0.0571
48 ABSCESS FUNGAL 10 0.0571
49 LOWER RESPIRATORY TRACT INFECTION FUNGAL 22 0.0566
50 CONGENITAL APLASIA 17 0.0547
51 GRAFT VERSUS HOST DISEASE IN LUNG 26 0.0544
52 GASTROINTESTINAL MUCORMYCOSIS 9 0.0539
53 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 10 0.0535
54 PNEUMONIA FUNGAL 199 0.0504
55 GRAFT VERSUS HOST DISEASE IN LIVER 36 0.0503
56 ANTICOAGULATION DRUG LEVEL INCREASED 16 0.0498
57 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 106 0.0498
58 CYSTITIS VIRAL 19 0.0496
59 ENTEROBACTER TEST POSITIVE 12 0.0488
60 ZYGOMYCOSIS 22 0.0470
61 HERPES SIMPLEX REACTIVATION 17 0.0446
62 GRAFT VERSUS HOST DISEASE IN SKIN 96 0.0435
63 DISSEMINATED MUCORMYCOSIS 17 0.0431
64 ASPERGILLUS TEST POSITIVE 13 0.0422
65 SYSTEMIC CANDIDA 105 0.0418
66 INTRAOCULAR PRESSURE TEST 10 0.0417
67 FUNGAEMIA 62 0.0394
68 ASPERGILLUS INFECTION 255 0.0388
69 ECTHYMA 15 0.0374
70 SINUSITIS FUNGAL 30 0.0374
71 GRAFT VERSUS HOST DISEASE 265 0.0368
72 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 52 0.0368
73 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
74 CEREBRAL TOXOPLASMOSIS 34 0.0364
75 SEPTIC EMBOLUS 30 0.0361
76 KLEBSIELLA BACTERAEMIA 34 0.0358
77 ENTEROCOCCAL BACTERAEMIA 37 0.0349
78 UREAPLASMA INFECTION 14 0.0343
79 GRAFT COMPLICATION 20 0.0341
80 VIRAL HAEMORRHAGIC CYSTITIS 24 0.0337
81 BRONCHOPULMONARY ASPERGILLOSIS 256 0.0330
82 CYTOMEGALOVIRUS INFECTION REACTIVATION 145 0.0328
83 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 23 0.0320
84 GROWTH FAILURE 11 0.0320
85 RESPIRATORY TRACT INFECTION FUNGAL 16 0.0303
86 IDIOPATHIC PNEUMONIA SYNDROME 9 0.0302
87 VENOUS HAEMORRHAGE 9 0.0290
88 PARAINFLUENZAE VIRUS INFECTION 44 0.0289
89 TRANSPLANTATION COMPLICATION 12 0.0286
90 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 79 0.0286
91 CHRONIC GRAFT VERSUS HOST DISEASE 102 0.0282
92 CITROBACTER INFECTION 12 0.0280
93 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0275
94 CHOROIDAL EFFUSION 22 0.0274
95 ENTEROBACTER SEPSIS 10 0.0270
96 CARDIAC VALVE VEGETATION 13 0.0267
97 NEUTROPENIC INFECTION 25 0.0261
98 HYPERLEUKOCYTOSIS 23 0.0260
99 KLEBSIELLA SEPSIS 29 0.0257
100 SINOATRIAL BLOCK 15 0.0252
101 NECROTISING RETINITIS 16 0.0250
102 BK VIRUS INFECTION 81 0.0240
103 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 22 0.0238
104 GLUCOCORTICOID DEFICIENCY 10 0.0236
105 STENOTROPHOMONAS INFECTION 32 0.0236
106 PSEUDOMONAL BACTERAEMIA 20 0.0234
107 PLATELET TRANSFUSION 30 0.0233
108 RETINAL ISCHAEMIA 14 0.0229
109 CARDIOACTIVE DRUG LEVEL INCREASED 30 0.0228
110 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 14 0.0213
111 BRAIN ABSCESS 54 0.0213
112 LUNG TRANSPLANT REJECTION 14 0.0212
113 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 69 0.0209
114 ESCHERICHIA BACTERAEMIA 49 0.0208
115 LEUKAEMIA RECURRENT 35 0.0207
116 ASPERGILLOSIS 27 0.0207
117 ACUTE MYELOID LEUKAEMIA 321 0.0206
118 MYOPERICARDITIS 16 0.0205
119 NEUTROPENIC COLITIS 42 0.0203
120 ENTEROCOCCAL INFECTION 98 0.0203
121 DRUG LEVEL BELOW THERAPEUTIC 111 0.0201
122 BRAIN COMPRESSION 8 0.0200
123 ENTEROCOCCAL SEPSIS 16 0.0198
124 PULMONARY NOCARDIOSIS 16 0.0194
125 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 9 0.0192
126 POLYMYOSITIS 34 0.0192
127 PSEUDOMONAL SEPSIS 33 0.0188
128 MINIMAL RESIDUAL DISEASE 9 0.0186
129 ENGRAFTMENT SYNDROME 11 0.0186
130 STAPHYLOCOCCAL BACTERAEMIA 80 0.0184
131 COAGULATION TEST ABNORMAL 14 0.0182
132 INFECTIVE ANEURYSM 9 0.0182
133 MYCOBACTERIUM ABSCESSUS INFECTION 13 0.0182
134 ANAEMIA MEGALOBLASTIC 8 0.0179
135 METAPNEUMOVIRUS INFECTION 14 0.0179
136 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0173
137 HAEMATOLOGICAL INFECTION 42 0.0172
138 HYPOFIBRINOGENAEMIA 17 0.0171
139 FEBRILE NEUTROPENIA 1099 0.0166
140 SOFT TISSUE INFECTION 30 0.0164
141 APLASIA 32 0.0163
142 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 21 0.0159
143 PULMONARY MYCOSIS 12 0.0154
144 BLAST CELL COUNT INCREASED 16 0.0153
145 INTRACRANIAL MASS 14 0.0148
146 PNEUMONIA KLEBSIELLA 27 0.0147
147 STEROID DIABETES 22 0.0147
148 ADENOVIRUS INFECTION 42 0.0145
149 FUNGAL SEPSIS 12 0.0144
150 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 85 0.0143
151 PNEUMONIA PSEUDOMONAL 22 0.0143
152 CYTOMEGALOVIRUS ENTEROCOLITIS 11 0.0143
153 PSEUDOMONAS INFECTION 122 0.0142
154 BACTERAEMIA 168 0.0141
155 STREPTOCOCCAL BACTERAEMIA 15 0.0138
156 ACUTE LYMPHOCYTIC LEUKAEMIA 39 0.0138
157 BONE MARROW TRANSPLANT 26 0.0137
158 NOCARDIOSIS 35 0.0137
159 COCCIDIOIDOMYCOSIS 16 0.0134
160 SINUSITIS BACTERIAL 14 0.0133
161 HYPERBILIRUBINAEMIA 137 0.0132
162 OESOPHAGITIS ULCERATIVE 9 0.0132
163 INFECTION REACTIVATION 15 0.0131
164 CYTOMEGALOVIRUS VIRAEMIA 58 0.0130
165 NEPHROGENIC DIABETES INSIPIDUS 15 0.0130
166 VENOOCCLUSIVE LIVER DISEASE 64 0.0129
167 STEM CELL TRANSPLANT 32 0.0128
168 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 10 0.0127
169 CEREBRAL ARTERY EMBOLISM 15 0.0123
170 CANDIDA SEPSIS 11 0.0123
171 ACUTE GRAFT VERSUS HOST DISEASE 56 0.0122
172 CYTOPENIA 149 0.0122
173 TUMOUR LYSIS SYNDROME 107 0.0121
174 KLEBSIELLA INFECTION 61 0.0121
175 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 31 0.0120
176 CYSTITIS HAEMORRHAGIC 48 0.0119
177 HEPATIC CYTOLYSIS 151 0.0118
178 BICYTOPENIA 23 0.0117
179 ESCHERICHIA SEPSIS 34 0.0117
180 BLOOD IMMUNOGLOBULIN G DECREASED 29 0.0117
181 AXONAL NEUROPATHY 10 0.0115
182 BACTERIAL SEPSIS 37 0.0113
183 CENTRAL NERVOUS SYSTEM INFECTION 13 0.0113
184 MYOSITIS 101 0.0112
185 PELVIC VENOUS THROMBOSIS 16 0.0112
186 BILIRUBIN CONJUGATED INCREASED 26 0.0111
187 CELL DEATH 22 0.0111
188 HYPOGONADISM 11 0.0109
189 EPSTEIN-BARR VIRAEMIA 12 0.0108
190 RENAL TUBULAR DISORDER 30 0.0107
191 CAPILLARY LEAK SYNDROME 22 0.0106
192 SECONDARY ADRENOCORTICAL INSUFFICIENCY 16 0.0106
193 SEPTIC SHOCK 461 0.0106
194 ILEUS PARALYTIC 47 0.0105
195 TRANSPLANT 25 0.0105
196 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 64 0.0105
197 BRAIN HERNIATION 31 0.0104
198 STAPHYLOCOCCAL SEPSIS 51 0.0103
199 LUNG OPACITY 27 0.0102
200 CYTOMEGALOVIRUS TEST POSITIVE 18 0.0101
201 RENAL TUBULAR ACIDOSIS 22 0.0101
202 LONG QT SYNDROME 24 0.0100
203 MUSCLE NECROSIS 9 0.0099
204 INFECTIOUS PLEURAL EFFUSION 15 0.0098
205 PATHOGEN RESISTANCE 89 0.0098
206 LUNG CONSOLIDATION 27 0.0096
207 CHOLESTASIS 185 0.0096
208 PULMONARY SEPSIS 14 0.0096
209 ENTEROBACTER INFECTION 16 0.0095
210 ADRENAL SUPPRESSION 8 0.0095
211 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 71 0.0095
212 THROMBOTIC MICROANGIOPATHY 92 0.0094
213 FEBRILE INFECTION 11 0.0093
214 PNEUMONIA CYTOMEGALOVIRAL 18 0.0093
215 CYTOKINE RELEASE SYNDROME 185 0.0092
216 CYTOMEGALOVIRUS INFECTION 152 0.0091
217 LEUKOENCEPHALOPATHY 34 0.0091
218 ENCEPHALITIS VIRAL 11 0.0090
219 FEBRILE BONE MARROW APLASIA 38 0.0089
220 DEVICE RELATED INFECTION 134 0.0087
221 ACUTE LEUKAEMIA 14 0.0087
222 EXTREMITY NECROSIS 15 0.0086
223 ATRIOVENTRICULAR BLOCK SECOND DEGREE 26 0.0086
224 HEPATIC NECROSIS 32 0.0085
225 BONE MARROW TOXICITY 10 0.0084
226 OBLITERATIVE BRONCHIOLITIS 11 0.0084
227 ATYPICAL PNEUMONIA 25 0.0084
228 ESCHERICHIA TEST POSITIVE 10 0.0083
229 TORSADE DE POINTES 64 0.0081
230 OPTIC NEUROPATHY 17 0.0080
231 HERPES SIMPLEX 52 0.0080
232 RHINOVIRUS INFECTION 31 0.0080
233 DRUG LEVEL DECREASED 81 0.0080
234 HYPOGAMMAGLOBULINAEMIA 52 0.0079
235 JUGULAR VEIN THROMBOSIS 14 0.0079
236 ANGLE CLOSURE GLAUCOMA 20 0.0078
237 MULTIPLE ORGAN DYSFUNCTION SYNDROME 221 0.0078
238 METHAEMOGLOBINAEMIA 18 0.0078
239 EPSTEIN-BARR VIRUS INFECTION 48 0.0077
240 ENTEROCOLITIS 44 0.0076
241 BONE MARROW DISORDER 23 0.0076
242 DRUG RESISTANCE 194 0.0075
243 NEPHROPATHY TOXIC 84 0.0075
244 PLASMA CELL MYELOMA REFRACTORY 10 0.0075
245 NEUTROPENIC SEPSIS 53 0.0074
246 SKIN NECROSIS 38 0.0073
247 ACINETOBACTER INFECTION 8 0.0073
248 APLASTIC ANAEMIA 38 0.0073
249 PANCYTOPENIA 402 0.0072
250 ACUTE PULMONARY OEDEMA 40 0.0071
251 HYPOMAGNESAEMIA 99 0.0071
252 LEUKAEMIA 67 0.0071
253 FUNGAL INFECTION 236 0.0071
254 PRODUCT DEPOSIT 11 0.0071
255 CANDIDA INFECTION 119 0.0070
256 INHIBITORY DRUG INTERACTION 11 0.0069
257 HYPERAMMONAEMIC ENCEPHALOPATHY 12 0.0069
258 HUMAN HERPESVIRUS 6 INFECTION 13 0.0069
259 HEPATOCELLULAR INJURY 97 0.0068
260 HYPOPHOSPHATAEMIA 50 0.0068
261 HYPOKALAEMIA 311 0.0067
262 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 64 0.0067
263 HOSPICE CARE 66 0.0067
264 BONE MARROW FAILURE 135 0.0066
265 CYTOLYTIC HEPATITIS 22 0.0066
266 GASTRIC DILATATION 11 0.0066
267 DRUG INTERACTION 1042 0.0066
268 HEPATOTOXICITY 146 0.0066
269 ELECTROCARDIOGRAM QT PROLONGED 235 0.0065
270 DEVICE RELATED SEPSIS 13 0.0065
271 VASCULAR PURPURA 9 0.0064
272 GASTROINTESTINAL TOXICITY 31 0.0064
273 NEUROTOXICITY 113 0.0064
274 DRUG LEVEL INCREASED 105 0.0063
275 DRUG LEVEL ABOVE THERAPEUTIC 29 0.0063
276 MIXED LIVER INJURY 19 0.0063
277 FUNGAL SKIN INFECTION 25 0.0062
278 CYTOMEGALOVIRUS COLITIS 14 0.0061
279 HEPATITIS FULMINANT 18 0.0061
280 VENOOCCLUSIVE DISEASE 15 0.0060
281 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 13 0.0059
282 BACTERIAL INFECTION 110 0.0059
283 LUNG INFILTRATION 52 0.0059
284 LUNG ABSCESS 12 0.0057
285 ENDOPHTHALMITIS 34 0.0057
286 NEUTROPENIA 770 0.0057
287 ORGANISING PNEUMONIA 28 0.0056
288 PERIPHERAL SENSORY NEUROPATHY 33 0.0056
289 JC VIRUS INFECTION 9 0.0056
290 STUPOR 18 0.0056
291 DISINHIBITION 9 0.0056
292 CLOSTRIDIUM DIFFICILE COLITIS 59 0.0056
293 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 57 0.0055
294 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 13 0.0055
295 MULTIPLE-DRUG RESISTANCE 17 0.0055
296 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
297 SERUM SICKNESS 15 0.0054
298 MYOCARDIAL NECROSIS MARKER INCREASED 9 0.0054
299 ESCHERICHIA INFECTION 44 0.0053
300 VARICELLA ZOSTER VIRUS INFECTION 11 0.0053
301 TRANSPLANT FAILURE 13 0.0053
302 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46 0.0053
303 MYCOBACTERIAL INFECTION 9 0.0052
304 MYCOBACTERIUM AVIUM COMPLEX INFECTION 14 0.0052
305 ORGAN FAILURE 21 0.0052
306 ACUTE RESPIRATORY DISTRESS SYNDROME 92 0.0052
307 CYTOMEGALOVIRUS CHORIORETINITIS 10 0.0051
308 RASH MACULO-PAPULAR 114 0.0051
309 ENCEPHALOPATHY 125 0.0051
310 VASCULAR DEVICE INFECTION 23 0.0051
311 MUCOSAL INFLAMMATION 132 0.0050
312 PROCTITIS 14 0.0050
313 TRANSPLANT REJECTION 40 0.0050
314 HEPATITIS TOXIC 13 0.0050
315 THROMBOCYTOPENIA 551 0.0049
316 ENDOCARDITIS 25 0.0049
317 OTOTOXICITY 9 0.0049
318 VITRITIS 9 0.0049
319 ENTERITIS 31 0.0048
320 JAUNDICE CHOLESTATIC 17 0.0048
321 LUNG TRANSPLANT 17 0.0048
322 CHOLECYSTITIS ACUTE 27 0.0048
323 CEREBRAL HAEMATOMA 16 0.0048
324 NEUROLOGICAL DECOMPENSATION 11 0.0047
325 CUSHINGOID 15 0.0047
326 LYMPHOPENIA 66 0.0047
327 PULMONARY ALVEOLAR HAEMORRHAGE 26 0.0046
328 CARDIAC DYSFUNCTION 17 0.0046
329 CATHETER SITE INFECTION 17 0.0045
330 POTENTIATING DRUG INTERACTION 15 0.0045
331 TONGUE ULCERATION 15 0.0044
332 PERICARDIAL EFFUSION 102 0.0044
333 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 39 0.0044
334 GASTROINTESTINAL TUBE INSERTION 11 0.0044
335 STAPHYLOCOCCAL INFECTION 145 0.0044
336 SERUM FERRITIN INCREASED 23 0.0044
337 PNEUMONIA BACTERIAL 40 0.0044
338 PRODUCT USE IN UNAPPROVED INDICATION 1074 0.0043
339 METABOLIC ENCEPHALOPATHY 13 0.0043
340 HEPATITIS CHOLESTATIC 26 0.0043
341 LIVER ABSCESS 14 0.0043
342 HAEMOLYTIC URAEMIC SYNDROME 10 0.0043
343 ELECTROLYTE IMBALANCE 49 0.0042
344 MALABSORPTION 22 0.0042
345 IMMUNOSUPPRESSION 37 0.0042
346 EXOPHTHALMOS 9 0.0042
347 HYPOXIA 147 0.0042
348 BLOOD LACTATE DEHYDROGENASE INCREASED 66 0.0042
349 AGRANULOCYTOSIS 77 0.0041
350 ORAL DISORDER 30 0.0041
351 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
352 MYELODYSPLASTIC SYNDROME 59 0.0041
353 BRAIN OEDEMA 51 0.0040
354 PULMONARY MASS 60 0.0040
355 BLOOD BILIRUBIN INCREASED 108 0.0040
356 MULTI-ORGAN FAILURE 69 0.0040
357 HYPOALBUMINAEMIA 31 0.0040
358 CHRONIC GASTRITIS 9 0.0040
359 PULMONARY HAEMORRHAGE 31 0.0040
360 HEPATIC LESION 17 0.0039
361 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 20 0.0039
362 ENDOTRACHEAL INTUBATION 11 0.0039
363 ISCHAEMIC CARDIOMYOPATHY 12 0.0039
364 TRANSFUSION 41 0.0039
365 TRANSAMINASES INCREASED 87 0.0039
366 DISSEMINATED INTRAVASCULAR COAGULATION 55 0.0039
367 MYELOSUPPRESSION 140 0.0039
368 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9 0.0039
369 PARONYCHIA 17 0.0039
370 RESPIRATORY FAILURE 282 0.0039
371 NEUROLOGICAL SYMPTOM 22 0.0038
372 DRUG-INDUCED LIVER INJURY 120 0.0038
373 SEPSIS 425 0.0038
374 AREFLEXIA 10 0.0037
375 SINUS BRADYCARDIA 36 0.0037
376 ACUTE RESPIRATORY FAILURE 71 0.0037
377 RENAL TUBULAR NECROSIS 36 0.0037
378 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
379 FAILURE TO THRIVE 19 0.0037
380 ENCEPHALITIS 25 0.0036
381 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
382 MONOCYTE COUNT INCREASED 13 0.0036
383 CARDIAC TAMPONADE 17 0.0036
384 HEPATOMEGALY 35 0.0036
385 OLIGURIA 22 0.0035
386 NEUTROPHIL COUNT ABNORMAL 10 0.0035
387 RETINAL HAEMORRHAGE 25 0.0035
388 BRONCHOPNEUMONIA 12 0.0035
389 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
390 TOXIC SKIN ERUPTION 35 0.0035
391 VITAMIN B12 DECREASED 10 0.0035
392 NEUTROPHIL COUNT DECREASED 141 0.0035
393 HYPERVOLAEMIA 17 0.0034
394 HYPOVENTILATION 11 0.0034
395 TOXIC ENCEPHALOPATHY 17 0.0034
396 CENTRAL NERVOUS SYSTEM LESION 46 0.0033
397 CENTRAL VENOUS CATHETERISATION 10 0.0033
398 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
399 HYPERTRANSAMINASAEMIA 23 0.0033
400 CARDIAC FAILURE ACUTE 22 0.0033
401 HEPATIC FAILURE 99 0.0033
402 HAEMODYNAMIC INSTABILITY 25 0.0033
403 AMYLASE INCREASED 12 0.0032
404 CANDIDIASIS 13 0.0032
405 DIASTOLIC DYSFUNCTION 10 0.0032
406 MALNUTRITION 36 0.0032
407 HYPERNATRAEMIA 16 0.0032
408 PERIPHERAL VENOUS DISEASE 13 0.0032
409 BLOOD CREATININE ABNORMAL 11 0.0032
410 GENERALISED OEDEMA 39 0.0031
411 PAPULE 22 0.0031
412 CACHEXIA 16 0.0031
413 IMMUNODEFICIENCY 46 0.0031
414 HYPERPYREXIA 13 0.0031
415 ILEUS 38 0.0031
416 ADRENAL INSUFFICIENCY 37 0.0030
417 TOXIC EPIDERMAL NECROLYSIS 46 0.0030
418 SCLERODERMA 11 0.0030
419 ACUTE KIDNEY INJURY 462 0.0030
420 BLOOD PHOSPHORUS DECREASED 11 0.0030
421 DERMATITIS EXFOLIATIVE 15 0.0030
422 LEFT VENTRICULAR DYSFUNCTION 20 0.0030
423 PULMONARY FUNCTION TEST DECREASED 13 0.0030
424 ANAL ABSCESS 16 0.0030
425 PLEURAL EFFUSION 179 0.0029
426 BLOOD PHOSPHORUS INCREASED 8 0.0029
427 LEUKOCYTOSIS 53 0.0029
428 PROTEIN TOTAL DECREASED 11 0.0029
429 APLASIA PURE RED CELL 10 0.0029
430 LUNG INFECTION 45 0.0029
431 VENTRICULAR FIBRILLATION 32 0.0029
432 PLATELET COUNT DECREASED 306 0.0029
433 IRIDOCYCLITIS 9 0.0028
434 THROMBOTIC THROMBOCYTOPENIC PURPURA 10 0.0028
435 SHOCK HAEMORRHAGIC 23 0.0028
436 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
437 SQUAMOUS CELL CARCINOMA OF SKIN 17 0.0028
438 HYPERAMMONAEMIA 14 0.0028
439 BLOOD ALBUMIN DECREASED 22 0.0028
440 AZOTAEMIA 11 0.0028
441 RESPIRATORY DISTRESS 75 0.0027
442 SKIN MASS 18 0.0027
443 NECROSIS 15 0.0027
444 ARTHRITIS BACTERIAL 11 0.0027
445 SKIN INFECTION 30 0.0027
446 BLOOD CULTURE POSITIVE 8 0.0027
447 CATATONIA 14 0.0027
448 PYREXIA 921 0.0027
449 DRUG ERUPTION 47 0.0026
450 DISEASE PROGRESSION 313 0.0026
451 PROCTALGIA 17 0.0026
452 FULL BLOOD COUNT DECREASED 53 0.0026
453 RED BLOOD CELL COUNT DECREASED 75 0.0026
454 HYPERTHERMIA 20 0.0026
455 ABDOMINAL TENDERNESS 13 0.0026
456 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
457 PURPURA 23 0.0026
458 BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0026
459 MENTAL STATUS CHANGES 72 0.0026
460 LARGE INTESTINE PERFORATION 18 0.0026
461 DECUBITUS ULCER 21 0.0026
462 VASCULITIS 30 0.0026
463 PURULENT DISCHARGE 11 0.0026
464 BLOOD MAGNESIUM DECREASED 22 0.0025
465 MYOPATHY 22 0.0025
466 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 139 0.0025
467 CHRONIC LYMPHOCYTIC LEUKAEMIA 12 0.0025
468 HAEMOPTYSIS 70 0.0025
469 PANCREATITIS ACUTE 56 0.0025
470 LIVER FUNCTION TEST ABNORMAL 72 0.0025
471 CLOSTRIDIUM DIFFICILE INFECTION 54 0.0025
472 HEPATITIS ACUTE 16 0.0025
473 COVID-19 PNEUMONIA 29 0.0025
474 THROMBOCYTOSIS 9 0.0025
475 EJECTION FRACTION DECREASED 38 0.0024
476 BLOOD COUNT ABNORMAL 37 0.0024
477 SUSPECTED OFF LABEL USE 11 0.0024
478 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12 0.0024
479 HEPATIC ENZYME ABNORMAL 12 0.0024
480 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
481 HYPERTRIGLYCERIDAEMIA 14 0.0024
482 CHEMOTHERAPY 9 0.0024
483 HALLUCINATIONS, MIXED 10 0.0024
484 ABSCESS LIMB 10 0.0023
485 HAEMOLYSIS 18 0.0023
486 OCULAR ICTERUS 10 0.0023
487 VENTRICULAR TACHYCARDIA 38 0.0023
488 LIVER INJURY 56 0.0023
489 HEPATIC FUNCTION ABNORMAL 85 0.0023
490 ATELECTASIS 22 0.0023
491 MENINGITIS 15 0.0022
492 ASCITES 66 0.0022
493 GASTROINTESTINAL INFECTION 20 0.0022
494 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38 0.0022
495 ANURIA 19 0.0022
496 PETECHIAE 23 0.0022
497 ORAL HERPES 43 0.0022
498 ORAL CANDIDIASIS 29 0.0022
499 FOLLICULITIS 23 0.0022
500 FULL BLOOD COUNT ABNORMAL 23 0.0022
501 SUBDURAL HAEMATOMA 31 0.0022
502 LOWER GASTROINTESTINAL HAEMORRHAGE 16 0.0022
503 CELLULITIS 109 0.0022
504 PNEUMONIA 698 0.0022
505 SKIN LESION 59 0.0021
506 PLATELET COUNT ABNORMAL 13 0.0021
507 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55 0.0021
508 HALLUCINATION, VISUAL 45 0.0021
509 HYPONATRAEMIA 120 0.0021
510 INFECTION 304 0.0021
511 LIPASE INCREASED 16 0.0021
512 GUILLAIN-BARRE SYNDROME 10 0.0021
513 RENAL FAILURE 274 0.0021
514 C-REACTIVE PROTEIN INCREASED 75 0.0021
515 LEUKOPENIA 103 0.0021
516 GINGIVAL BLEEDING 28 0.0020
517 SPLENOMEGALY 24 0.0020
518 ASPARTATE AMINOTRANSFERASE INCREASED 108 0.0020
519 RENAL IMPAIRMENT 169 0.0020
520 POLYNEUROPATHY 24 0.0020
521 ALANINE AMINOTRANSFERASE INCREASED 123 0.0020
522 HAEMATOTOXICITY 19 0.0020
523 CYSTIC FIBROSIS 11 0.0020
524 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
525 TREATMENT FAILURE 163 0.0020
526 HAEMATOCRIT DECREASED 39 0.0020
527 IMMUNE THROMBOCYTOPENIA 9 0.0020
528 LIVER FUNCTION TEST INCREASED 42 0.0020
529 OFF LABEL USE 1706 0.0019
530 ATRIOVENTRICULAR BLOCK 15 0.0019
531 PERIORBITAL OEDEMA 10 0.0019
532 FLUID OVERLOAD 28 0.0019
533 COAGULOPATHY 32 0.0019
534 ASPIRATION 21 0.0019
535 CARDIOMYOPATHY 28 0.0019
536 RALES 11 0.0019
537 OBSTRUCTIVE AIRWAYS DISORDER 21 0.0019
538 ABSCESS 30 0.0019
539 SUBCUTANEOUS ABSCESS 9 0.0019
540 WHITE BLOOD CELL COUNT DECREASED 203 0.0019
541 HAEMOGLOBIN ABNORMAL 12 0.0019
542 BRAIN FOG 29 0.0018
543 COLITIS 70 0.0018
544 INCORRECT DOSAGE ADMINISTERED 9 0.0018
545 TROPONIN INCREASED 14 0.0018
546 NODULE 24 0.0018
547 TACHYPNOEA 25 0.0018
548 HYPOPHAGIA 47 0.0018
549 FACE OEDEMA 31 0.0018
550 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 15 0.0018
551 DIFFUSE LARGE B-CELL LYMPHOMA 14 0.0018
552 INFLAMMATORY MARKER INCREASED 9 0.0018
553 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
554 SQUAMOUS CELL CARCINOMA 17 0.0018
555 HEPATITIS 46 0.0018
556 HYPOCALCAEMIA 34 0.0018
557 RESPIRATORY DISORDER 53 0.0018
558 STATUS EPILEPTICUS 20 0.0018
559 PHOTOSENSITIVITY REACTION 29 0.0018
560 HYDRONEPHROSIS 13 0.0017
561 RHINITIS 14 0.0017
562 HERPES VIRUS INFECTION 10 0.0017
563 BLOOD URIC ACID INCREASED 10 0.0017
564 BLOOD CREATININE INCREASED 113 0.0017
565 RESPIRATORY TRACT INFECTION 45 0.0017
566 PARTIAL SEIZURES 9 0.0017
567 BRADYCARDIA 91 0.0017
568 MOUTH ULCERATION 36 0.0017
569 DELIRIUM 59 0.0017
570 SINUS TACHYCARDIA 24 0.0017
571 ANAL FISTULA 9 0.0017
572 HYPOTHERMIA 17 0.0017
573 MITRAL VALVE INCOMPETENCE 19 0.0017
574 ANAEMIA 320 0.0017
575 CEREBRAL HAEMORRHAGE 60 0.0017
576 ODYNOPHAGIA 10 0.0017
577 HAEMOLYTIC ANAEMIA 15 0.0017
578 CARDIOGENIC SHOCK 24 0.0017
579 CARDIAC ARREST 138 0.0017
580 HAEMOGLOBIN DECREASED 170 0.0017
581 RHABDOMYOLYSIS 69 0.0017
582 LUNG DISORDER 81 0.0017
583 PNEUMONITIS 45 0.0017
584 CIRCULATORY COLLAPSE 28 0.0016
585 TRICUSPID VALVE INCOMPETENCE 13 0.0016
586 INTESTINAL ISCHAEMIA 9 0.0016
587 HYPERKALAEMIA 57 0.0016
588 NEPHROTIC SYNDROME 11 0.0016
589 HEPATIC ENZYME INCREASED 109 0.0016
590 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
591 MYOCARDITIS 18 0.0016
592 ACIDOSIS 12 0.0016
593 WHITE BLOOD CELL COUNT ABNORMAL 10 0.0016
594 SKIN ATROPHY 9 0.0016
595 PULMONARY OEDEMA 70 0.0016
596 BLOOD UREA INCREASED 26 0.0016
597 VENTRICULAR EXTRASYSTOLES 16 0.0015
598 ACUTE HEPATIC FAILURE 21 0.0015
599 TASTE DISORDER 31 0.0015
600 JAUNDICE 41 0.0015
601 ATAXIA 18 0.0015
602 CORONAVIRUS INFECTION 10 0.0015
603 PROTHROMBIN TIME PROLONGED 9 0.0015
604 MUSCLE ATROPHY 19 0.0015
605 BLOOD DISORDER 12 0.0015
606 PRODUCT USE ISSUE 281 0.0015
607 OEDEMA 81 0.0015
608 CONDITION AGGRAVATED 449 0.0015
609 VIRAL INFECTION 49 0.0015
610 POLYURIA 12 0.0015
611 HAEMATURIA 50 0.0015
612 ECCHYMOSIS 10 0.0015
613 TACHYCARDIA 129 0.0015
614 DIZZINESS POSTURAL 14 0.0014
615 METABOLIC ACIDOSIS 46 0.0014
616 HAEMORRHOIDS 28 0.0014
617 ADVERSE EVENT 132 0.0014
618 BLOOD POTASSIUM DECREASED 43 0.0014
619 CHOLECYSTITIS 17 0.0014
620 BLOOD CALCIUM DECREASED 16 0.0014
621 THERAPY PARTIAL RESPONDER 22 0.0014
622 MELAENA 31 0.0014
623 GASTROINTESTINAL INFLAMMATION 11 0.0014
624 PRODUCT DISTRIBUTION ISSUE 13 0.0014
625 SKIN HYPERPIGMENTATION 12 0.0014
626 NO THERAPEUTIC RESPONSE 17 0.0014
627 GENERAL PHYSICAL HEALTH DETERIORATION 160 0.0014
628 HYPERCALCAEMIA 17 0.0014
629 FAECES SOFT 10 0.0014
630 HYPERGLYCAEMIA 50 0.0014
631 MAJOR DEPRESSION 10 0.0014
632 DISEASE RECURRENCE 65 0.0014
633 LYMPHOCYTE COUNT DECREASED 24 0.0014
634 STEVENS-JOHNSON SYNDROME 30 0.0013
635 ANAL INCONTINENCE 12 0.0013
636 ORTHOSTATIC HYPOTENSION 23 0.0013
637 RENAL DISORDER 61 0.0013
638 LIVER DISORDER 58 0.0013
639 JOINT EFFUSION 9 0.0013
640 NEOPLASM 15 0.0013
641 NEUROPATHY PERIPHERAL 124 0.0013
642 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
643 EMPHYSEMA 13 0.0013
644 HALLUCINATION 97 0.0013
645 HEPATIC ENCEPHALOPATHY 12 0.0013
646 OESOPHAGITIS 14 0.0013
647 SUBARACHNOID HAEMORRHAGE 13 0.0013
648 THERAPY NON-RESPONDER 57 0.0013
649 PNEUMOTHORAX 20 0.0013
650 URINE OUTPUT DECREASED 11 0.0013
651 ATRIAL FLUTTER 10 0.0013
652 INTESTINAL PERFORATION 14 0.0012
653 ATRIAL FIBRILLATION 120 0.0012
654 MYOCARDIAL ISCHAEMIA 14 0.0012
655 TOXICITY TO VARIOUS AGENTS 205 0.0012
656 GASTROINTESTINAL HAEMORRHAGE 101 0.0012
657 ACUTE CORONARY SYNDROME 10 0.0012
658 HAEMORRHAGE INTRACRANIAL 18 0.0012
659 CARDIAC FAILURE 96 0.0012
660 PRODUCT PRESCRIBING ISSUE 26 0.0012
661 APPENDICITIS 11 0.0012
662 SHOCK 27 0.0012
663 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
664 HYPOTENSION 235 0.0012
665 EPISTAXIS 87 0.0012
666 NERVOUS SYSTEM DISORDER 36 0.0012
667 DEATH 993 0.0012
668 LABORATORY TEST ABNORMAL 34 0.0012
669 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
670 DRUG INEFFECTIVE 1513 0.0011
671 INTERNAL HAEMORRHAGE 13 0.0011
672 SUDDEN DEATH 12 0.0011
673 PERICARDITIS 19 0.0011
674 GINGIVAL PAIN 9 0.0011
675 HAEMORRHAGE 118 0.0011
676 RENAL FAILURE ACUTE 47 0.0011
677 MUSCULAR WEAKNESS 125 0.0011
678 BRAIN INJURY 11 0.0011
679 WHITE BLOOD CELL COUNT INCREASED 42 0.0011
680 APHASIA 33 0.0011
681 CARDIAC FAILURE CONGESTIVE 87 0.0011
682 BODY TEMPERATURE INCREASED 22 0.0011
683 DRUG INTOLERANCE 104 0.0011
684 ERYTHEMA MULTIFORME 10 0.0011
685 BLOOD TEST ABNORMAL 15 0.0011
686 PULMONARY EMBOLISM 101 0.0011
687 HEMIPARESIS 18 0.0011
688 BLOOD PRESSURE ABNORMAL 21 0.0011
689 PRODUCT AVAILABILITY ISSUE 24 0.0011
690 AORTIC ANEURYSM 8 0.0011
691 LACTIC ACIDOSIS 34 0.0010
692 OEDEMA PERIPHERAL 126 0.0010
693 DEEP VEIN THROMBOSIS 67 0.0010
694 COMA 49 0.0010
695 PRESYNCOPE 25 0.0010
696 ARRHYTHMIA 48 0.0010
697 INTERSTITIAL LUNG DISEASE 49 0.0010
698 HYPERTENSIVE CRISIS 11 0.0010
699 LYMPHADENOPATHY 35 0.0010
700 CHILLS 115 0.0010
701 CARDIO-RESPIRATORY ARREST 41 0.0010
702 ABNORMAL FAECES 8 0.0010
703 SMALL INTESTINAL OBSTRUCTION 12 0.0010
704 EOSINOPHILIA 17 0.0010
705 PHARYNGITIS 12 0.0010
706 SCAB 11 0.0010
707 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
708 CONTRAINDICATED PRODUCT ADMINISTERED 29 0.0010
709 RENAL INJURY 28 0.0009
710 CYSTITIS 30 0.0009
711 DECREASED APPETITE 217 0.0009
712 DYSPNOEA EXERTIONAL 35 0.0009
713 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
714 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 27 0.0009
715 NEOPLASM PROGRESSION 32 0.0009
716 LOCALISED INFECTION 22 0.0009
717 PANCREATITIS 48 0.0009
718 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
719 HYPERTENSION 192 0.0009
720 BLOOD SODIUM DECREASED 17 0.0009
721 ISCHAEMIC STROKE 16 0.0009
722 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
723 SKIN ULCER 23 0.0009
724 COVID-19 156 0.0009
725 OSTEOMYELITIS 16 0.0009
726 STOMATITIS 53 0.0009
727 URINARY TRACT INFECTION 149 0.0009
728 GASTROINTESTINAL DISORDER 78 0.0009
729 INTENTIONAL PRODUCT USE ISSUE 76 0.0009
730 HEPATIC STEATOSIS 16 0.0009
731 DISORIENTATION 34 0.0009
732 DIARRHOEA 550 0.0009
733 EPILEPSY 26 0.0008
734 HIATUS HERNIA 11 0.0008
735 HAEMATOMA 22 0.0008
736 FLUID RETENTION 43 0.0008
737 PLATELET COUNT INCREASED 11 0.0008
738 GASTRIC ULCER 16 0.0008
739 URINARY RETENTION 28 0.0008
740 OXYGEN SATURATION DECREASED 47 0.0008
741 TYPE 2 DIABETES MELLITUS 28 0.0008
742 DIVERTICULITIS 23 0.0008
743 PULMONARY THROMBOSIS 9 0.0008
744 NEURALGIA 20 0.0008
745 WOUND INFECTION 9 0.0008
746 SINUSITIS 84 0.0008
747 ABDOMINAL PAIN 190 0.0008
748 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58 0.0008
749 ORAL PAIN 18 0.0008
750 CONSTIPATION 173 0.0008
751 ASTHENIA 298 0.0008
752 HAEMATEMESIS 20 0.0008
753 CONFUSIONAL STATE 126 0.0008
754 DIALYSIS 11 0.0008
755 PRODUCTIVE COUGH 37 0.0008
756 TENDONITIS 12 0.0008
757 UNRESPONSIVE TO STIMULI 20 0.0008
758 BRONCHOSPASM 11 0.0008
759 PULMONARY HYPERTENSION 16 0.0008
760 DRY EYE 38 0.0008
761 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
762 HOSPITALISATION 116 0.0008
763 GASTROENTERITIS 11 0.0008
764 MALIGNANT MELANOMA 10 0.0007
765 BLOOD POTASSIUM INCREASED 12 0.0007
766 PROTEINURIA 14 0.0007
767 INFLAMMATION 38 0.0007
768 DRUG TOXICITY 10 0.0007
769 VOMITING 343 0.0007
770 DEHYDRATION 96 0.0007
771 SKIN DISORDER 24 0.0007
772 COUGH 200 0.0007
773 BLINDNESS UNILATERAL 10 0.0007
774 CHROMATURIA 16 0.0007
775 OSTEOPOROSIS 29 0.0007
776 MYDRIASIS 9 0.0007
777 PARALYSIS 10 0.0007
778 LETHARGY 40 0.0007
779 SEIZURE 80 0.0007
780 FEEDING DISORDER 14 0.0007
781 DRUG EFFECT INCOMPLETE 25 0.0007
782 TOOTH INFECTION 9 0.0007
783 SYNCOPE 68 0.0007
784 ACUTE MYOCARDIAL INFARCTION 20 0.0007
785 NAUSEA 536 0.0007
786 POST PROCEDURAL COMPLICATION 13 0.0007
787 VISUAL IMPAIRMENT 83 0.0007
788 PLASMA CELL MYELOMA 26 0.0007
789 BONE PAIN 39 0.0007
790 BLINDNESS 27 0.0007
791 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
792 ABDOMINAL DISTENSION 68 0.0007
793 INFLUENZA 72 0.0006
794 PNEUMONIA ASPIRATION 16 0.0006
795 SKIN EXFOLIATION 54 0.0006
796 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
797 TREMOR 105 0.0006
798 PERITONITIS 13 0.0006
799 RASH PRURITIC 34 0.0006
800 PALLOR 17 0.0006
801 MYALGIA 106 0.0006
802 PRESCRIBED OVERDOSE 12 0.0006
803 CEREBRAL INFARCTION 15 0.0006
804 CHOLELITHIASIS 20 0.0006
805 DYSPNOEA 344 0.0006
806 SKIN HAEMORRHAGE 9 0.0006
807 CATARACT 36 0.0006
808 SKIN CANCER 13 0.0006
809 AGEUSIA 15 0.0006
810 NO ADVERSE EVENT 108 0.0006
811 CONJUNCTIVITIS 11 0.0006
812 INSURANCE ISSUE 9 0.0006
813 RASH ERYTHEMATOUS 28 0.0006
814 MUSCULOSKELETAL CHEST PAIN 9 0.0006
815 THERAPEUTIC RESPONSE DECREASED 35 0.0006
816 DERMATITIS 12 0.0006
817 MUSCULOSKELETAL PAIN 30 0.0006
818 FATIGUE 443 0.0006
819 PERIPHERAL SWELLING 87 0.0006
820 CONVULSION 32 0.0006
821 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13 0.0006
822 CHEST DISCOMFORT 57 0.0006
823 SINUS DISORDER 11 0.0006
824 PRODUCT PRESCRIBING ERROR 13 0.0005
825 SKIN DISCOLOURATION 25 0.0005
826 DYSPHAGIA 51 0.0005
827 RIB FRACTURE 11 0.0005
828 THROMBOSIS 43 0.0005
829 PHOTOPHOBIA 10 0.0005
830 RASH 231 0.0005
831 MUSCULOSKELETAL DISORDER 10 0.0005
832 IMPAIRED HEALING 17 0.0005
833 RETCHING 11 0.0005
834 CHEST PAIN 95 0.0005
835 RECTAL HAEMORRHAGE 22 0.0005
836 TREATMENT NONCOMPLIANCE 28 0.0005
837 SOMNOLENCE 103 0.0005
838 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
839 RESPIRATORY ARREST 14 0.0005
840 FAECES DISCOLOURED 11 0.0005
841 MENTAL DISORDER 22 0.0005
842 AGITATION 37 0.0005
843 DIPLOPIA 13 0.0005
844 MALIGNANT NEOPLASM PROGRESSION 51 0.0005
845 ALOPECIA 97 0.0005
846 COGNITIVE DISORDER 23 0.0005
847 RASH PAPULAR 11 0.0005
848 PRODUCT DOSE OMISSION 32 0.0005
849 ANGINA PECTORIS 14 0.0005
850 CONTUSION 47 0.0005
851 OSTEONECROSIS 16 0.0005
852 LOSS OF CONSCIOUSNESS 62 0.0005
853 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 98 0.0005
854 ERYTHEMA 99 0.0005
855 BLISTER 27 0.0005
856 WEIGHT DECREASED 134 0.0005
857 PRODUCT DOSE OMISSION ISSUE 141 0.0005
858 NEOPLASM MALIGNANT 32 0.0005
859 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 86 0.0005
860 BALANCE DISORDER 41 0.0005
861 NIGHT SWEATS 15 0.0005
862 DYSURIA 17 0.0005
863 HEADACHE 289 0.0005
864 MOBILITY DECREASED 33 0.0005
865 DEAFNESS 12 0.0005
866 RASH MACULAR 16 0.0005
867 FEMUR FRACTURE 14 0.0005
868 PSYCHOTIC DISORDER 13 0.0004
869 BONE DISORDER 8 0.0004
870 INCORRECT DOSE ADMINISTERED 100 0.0004
871 INFUSION RELATED REACTION 29 0.0004
872 HERPES ZOSTER 25 0.0004
873 CARDIOVASCULAR DISORDER 11 0.0004
874 FALL 142 0.0004
875 EYE PAIN 24 0.0004
876 DIABETES MELLITUS 32 0.0004
877 DRY MOUTH 34 0.0004
878 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
879 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
880 PRODUCT DISPENSING ERROR 9 0.0004
881 HEAD INJURY 13 0.0004
882 URINARY INCONTINENCE 12 0.0004
883 ECZEMA 21 0.0004
884 UNEVALUABLE EVENT 30 0.0004
885 BACK PAIN 92 0.0004
886 DRUG ADMINISTRATION ERROR 12 0.0004
887 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
888 SWELLING FACE 25 0.0004
889 GASTRITIS 10 0.0004
890 VISION BLURRED 51 0.0004
891 OVERDOSE 80 0.0004
892 TINNITUS 17 0.0004
893 MUSCULOSKELETAL STIFFNESS 32 0.0004
894 BRONCHITIS 27 0.0004
895 ABDOMINAL DISCOMFORT 61 0.0004
896 DYSGEUSIA 27 0.0004
897 HAEMATOCHEZIA 20 0.0004
898 VISUAL ACUITY REDUCED 12 0.0004
899 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
900 PAIN IN JAW 10 0.0004
901 SWELLING 33 0.0004
902 HYPOGLYCAEMIA 17 0.0004
903 EYE SWELLING 13 0.0003
904 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
905 HIP FRACTURE 11 0.0003
906 MEDICATION ERROR 19 0.0003
907 ILLNESS 35 0.0003
908 EYE DISORDER 11 0.0003
909 ADVERSE DRUG REACTION 30 0.0003
910 DISTURBANCE IN ATTENTION 18 0.0003
911 BLOOD PRESSURE FLUCTUATION 8 0.0003
912 THERAPY CESSATION 17 0.0003
913 LACRIMATION INCREASED 10 0.0003
914 DYSPEPSIA 32 0.0003
915 RHINORRHOEA 21 0.0003
916 FEELING COLD 9 0.0003
917 DIZZINESS 161 0.0003
918 CARDIAC DISORDER 30 0.0003
919 BONE DENSITY DECREASED 10 0.0003
920 DYSARTHRIA 12 0.0003
921 GAIT DISTURBANCE 61 0.0003
922 UNDERDOSE 23 0.0003
923 HYPERSOMNIA 9 0.0003
924 OROPHARYNGEAL PAIN 29 0.0003
925 MALAISE 134 0.0003
926 PARAESTHESIA 48 0.0003
927 PRURITUS 117 0.0003
928 WHEEZING 18 0.0003
929 HEART RATE INCREASED 30 0.0003
930 ABDOMINAL PAIN UPPER 62 0.0003
931 ACCIDENTAL OVERDOSE 11 0.0003
932 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
933 ANGIOEDEMA 13 0.0003
934 COLITIS ULCERATIVE 13 0.0003
935 CHRONIC KIDNEY DISEASE 22 0.0003
936 BLOOD PRESSURE DECREASED 19 0.0003
937 DEPRESSED MOOD 15 0.0003
938 NEPHROLITHIASIS 13 0.0003
939 FLATULENCE 16 0.0003
940 WEIGHT INCREASED 63 0.0003
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
942 DRY SKIN 37 0.0003
943 PAIN IN EXTREMITY 81 0.0003
944 DYSPHONIA 16 0.0003
945 JOINT SWELLING 33 0.0003
946 ARTHRALGIA 113 0.0003
947 PAIN 165 0.0003
948 VERTIGO 16 0.0003
949 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
950 HYPOAESTHESIA 39 0.0003
951 INSOMNIA 69 0.0003
952 HYPOACUSIS 11 0.0003
953 MEMORY IMPAIRMENT 35 0.0003
954 DRUG DOSE OMISSION 42 0.0003
955 ANAPHYLACTIC REACTION 14 0.0003
956 ILL-DEFINED DISORDER 15 0.0002
957 POLLAKIURIA 10 0.0002
958 OSTEOARTHRITIS 10 0.0002
959 MYOCARDIAL INFARCTION 41 0.0002
960 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
961 URTICARIA 38 0.0002
962 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
963 BLOOD PRESSURE INCREASED 34 0.0002
964 NASAL CONGESTION 13 0.0002
965 MUSCLE SPASMS 40 0.0002
966 ANXIETY 62 0.0002
967 AMNESIA 14 0.0002
968 NECK PAIN 12 0.0002
969 SLEEP DISORDER 15 0.0002
970 FLUSHING 21 0.0002
971 PALPITATIONS 24 0.0002
972 ACNE 15 0.0002
973 BLOOD GLUCOSE INCREASED 37 0.0002
974 THERAPY INTERRUPTED 14 0.0002
975 BLOOD CHOLESTEROL INCREASED 9 0.0002
976 ARTHRITIS 15 0.0002
977 OCULAR HYPERAEMIA 9 0.0002
978 FEELING ABNORMAL 44 0.0002
979 ASTHMA 20 0.0002
980 NASOPHARYNGITIS 32 0.0002
981 HYPERSENSITIVITY 32 0.0002
982 SPEECH DISORDER 9 0.0002
983 INTENTIONAL PRODUCT MISUSE 15 0.0002
984 IRRITABILITY 10 0.0002
985 SUICIDAL IDEATION 15 0.0002
986 ARTHROPATHY 9 0.0002
987 INFLUENZA LIKE ILLNESS 13 0.0002
988 PRODUCT QUALITY ISSUE 21 0.0002
989 SURGERY 9 0.0002
990 FEELING HOT 9 0.0001
991 CEREBROVASCULAR ACCIDENT 24 0.0001
992 DEPRESSION 30 0.0001
993 HYPERHIDROSIS 15 0.0001
994 MIGRAINE 11 0.0001